RMY Stock Overview
Owns and operates hospitals in Australia, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 1/6 |
| Financial Health | 2/6 |
| Dividends | 4/6 |
Ramsay Health Care Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$23.20 |
| 52 Week High | AU$34.00 |
| 52 Week Low | AU$22.60 |
| Beta | 0.63 |
| 11 Month Change | -10.08% |
| 3 Month Change | -16.55% |
| 1 Year Change | -21.62% |
| 33 Year Change | -46.54% |
| 5 Year Change | -48.21% |
| Change since IPO | 280.33% |
Recent News & Updates
Recent updates
Shareholder Returns
| RMY | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 1.8% | -0.3% | -0.4% |
| 1Y | -21.6% | 14.5% | 7.1% |
Return vs Industry: RMY underperformed the German Healthcare industry which returned 17.2% over the past year.
Return vs Market: RMY underperformed the German Market which returned 7.8% over the past year.
Price Volatility
| RMY volatility | |
|---|---|
| RMY Average Weekly Movement | 3.9% |
| Healthcare Industry Average Movement | 4.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: RMY has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: RMY's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1964 | 90,000 | Craig McNally | www.ramsayhealth.com |
Ramsay Health Care Limited owns and operates hospitals in Australia, and internationally. The company offers health care services to public and private patients. Ramsay Health Care Limited was founded in 1964 and is based in Sydney, Australia.
Ramsay Health Care Limited Fundamentals Summary
| RMY fundamental statistics | |
|---|---|
| Market cap | €5.39b |
| Earnings (TTM) | €156.63m |
| Revenue (TTM) | €10.28b |
34.4x
P/E Ratio0.5x
P/S RatioIs RMY overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RMY income statement (TTM) | |
|---|---|
| Revenue | AU$16.66b |
| Cost of Revenue | AU$14.64b |
| Gross Profit | AU$2.02b |
| Other Expenses | AU$1.76b |
| Earnings | AU$253.90m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Feb 26, 2025
| Earnings per share (EPS) | 1.11 |
| Gross Margin | 12.10% |
| Net Profit Margin | 1.52% |
| Debt/Equity Ratio | 92.0% |
How did RMY perform over the long term?
See historical performance and comparison